The Breast
Volume 19, Issue 3 , Pages 172-175 , June 2010

What are the minimal standards of radiotherapy planning and dosimetry for “hypofractionated” radiotherapy in breast cancer?

  • N. MacLeod

      Affiliations

    • Division of Clinical Oncology, The Beatson West Of Scotland Cancer Centre, Great Western Road, Glasgow G12 0YN, United Kingdom
    • ,
  • A. McIntyre

      Affiliations

    • Radiography Department, The Beatson West Of Scotland Cancer Centre, Great Western Road, Glasgow G12 0YN, United Kingdom
    • ,
  • P.A. Canney

      Affiliations

    • Division of Clinical Oncology, The Beatson West Of Scotland Cancer Centre, Great Western Road, Glasgow G12 0YN, United Kingdom
    • Corresponding Author InformationCorresponding author.

References 

  1. Clark M, Collins R, Derby S, Davies C, Elphinston P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–2106
  2. Ving-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipselateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96:115–121
  3. Bartelink H, Horiot J-C, Poortmans P, Struikimans H, Vanden Bogaert W, Fourguet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007;25:3259–3265
  4. Whelan T, Kim D-H, Sussman J. Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radadiat Oncol. 2008;18:257–264
  5. The START trialists group. The UK standardization of radiotherapy START trial B of hypofractionation for treatment of early breast cancer: a randomized trial. Lancet. 2008;371:1098–07
  6. Jones B, Dale RG, Finst P, Khaksar SJ. Biological equivalent dose assessment of the consequences of hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47(5):1379–1384
  7. Hurkmans CW, Borger JH, Bos LJ, Van der Horst A, Pieters BR, Lebesque JV, et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol. 2000;55(2):145–151
  8. Gagliardi G, Lax I, Ottolennghi A, Rutqvist LE. Long-term cardiac mortality after radiotherapy of breast cancer – application of the relative seriality model. Brit J Rad. 1996;69:839–846
  9. Lind PA, Marks LB, Hardenbergh PH, Clough R, Fan M, Hollis D, et al. Technical factors associated with radiation pneumonitis after local ± regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(1):137–143
  10. Rothwell RI, Kelly S, Joslin CA. Radiation pneumonitis in patients treated for breast cancer. Radiother Oncol. 1985;4:9–14
  11. Jefferies S, Taylor A, Reznek R. Radiotherapy planning working party. Results of national survey of radiotherapy planning and delivery in the United Kingdom in 2007. Clin Oncol. 2009;21:204–217
  12. Aref A, Thornton D, Youssef E, He T, Tekyi-Mensah S, Denton L, et al. Dosimetric improvements following 3D planning of tangential breast irradiation. Int J Radiat Oncol Biol Phys. 2000;48(5):1569–1574
  13. Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hansan J, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol. 2007;82:254–264
  14. Pignol Jean-Philippe, Olivotto Ivo, Rakovitch Eileen, Gardener S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26(13):2085–2092
  15. ICRU . Prescribing, recording and reporting photon beam therapy. Bethsada: International Commision on Radiation units and Measurements (ICRU); 1993;
  16. ICRU . Prescribing, recording and reporting photon beam therapy. Bethsada: International Commision on Radiation units and Measurements (ICRU); 1999;
  17. Coles CE, Wilson CB, Cumming J, Benson JR, Forouh P, Wilkinson JS, et al. Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: audit on behalf of the IMPORT trial management group. Eur J Surg Oncol. 2009;35(6):578–582
  18. START – Standardisation of breast radiotherapy, trial protocol; 1998.
  19. Canney PA, Dickson J, Glegg M, Deehan C. Reducing cardiac doses in post-operative irradiation of breast cancer patients. Br J Radiol. 1999;72:986–993
  20. Galecki J, Hicer-Grzenkowicz J, Grudzien-Kowalska M, Michalska T, Zalucki W. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer – a review. 2006;45(3):280–284
  21. Barnett GC, Wilkinson J, Moody AM, Wilson CB, Sharma R, Klager S, et al. A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Phase III randomised trial. Radiother Oncol. July 2009;92(1):34–41
  22. Kestin LL, Sharpe MB, Frazier RC, Vicini FA, Yan D, Matter RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys. 2000;48:1559–1568
  23. Richmond ND, Turner RN, Dawes PJ, Lambert GD, Lawrence GP. Evaluation of the dosimetric consequences of adding a single asymmetric or MLC shaped field to a tangential breast radiotherapy technique. Radiother Oncol. 2003;67:165–170
  24. Donovan EM, Yarnold JR, Adams EJ, Morgan A, Warrington APJ, Evans PM. An investigation into methods of IMRT planning applied to breast radiotherapy. Br J Radiol. 2008;81(964):311–322
  25. Mihai A, Rakovitch E, Sixel K, Woo T, Cardoso M, Bell C, et al. Inverse vs forward breast IMRT planning. Med Dosim. 2005;30(3):149–154

PII: S0960-9776(10)00061-5

doi: 10.1016/j.breast.2010.03.007

The Breast
Volume 19, Issue 3 , Pages 172-175 , June 2010

Article Tools

* Image Usage & Resolution